Philippe Collin1, Xin Liu2, Patrick J Denard3, Soleen Gain1, Alexandra Nowak4, Alexandre Lädermann5. 1. Division of Orthopaedics and Trauma Surgery, Centre Hospitalier Privé Saint-Grégoire (Vivalto Santé), Saint-Grégoire, France. 2. Sports Medicine Service, Beijing Jishuitan Hospital, Beijing, China. 3. Southern Oregon Orthopedics, Medford, OR, USA; Department of Orthopaedics and Rehabilitation, Oregon Health & Science University, Portland, OR, USA. 4. Division of Orthopaedics and Trauma Surgery, La Tour Hospital, Meyrin, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland. 5. Division of Orthopaedics and Trauma Surgery, La Tour Hospital, Meyrin, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland; Division of Orthopaedics and Trauma Surgery, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland. Electronic address: alexandre.laedermann@gmail.com.
Abstract
BACKGROUND: To date, only a few comparative studies with small sample sizes have compared a traditional reverse shoulder arthroplasty (tRSA) to a bony increased-offset RSA (BIO-RSA). We hypothesized that the BIO-RSA would lead to lower notching rates and improved range of motion (ROM) compared with a tRSA. METHODS: A retrospective review was performed of 69 tRSAs and 61 BIO-RSAs performed by a single surgeon. At 2 years postoperative, ROM and Constant scores were compared. Radiographs were examined for scapular notching, scapular spurring or ossification, and graft healing. RESULTS: At the 2-year follow-up, the BIO-RSA group demonstrated improved anterior forward flexion compared with the tRSA group (145° ± 20° vs. 138° ± 20°, respectively; P = .017). There was no difference in external or internal rotation between the 2 groups. The BIO-RSA group had a higher Constant score than the tRSA group (69 ± 9 vs. 61 ± 13; P < .001). The radiographs showed no difference between the 2 groups, including scapular notching (P = .150). CONCLUSION: At the 2-year follow-up, BIO-RSA does not lead to a clinically significantly improvement in ROM, Constant scores, or change in scapular notching compared with a tRSA.
BACKGROUND: To date, only a few comparative studies with small sample sizes have compared a traditional reverse shoulder arthroplasty (tRSA) to a bony increased-offset RSA (BIO-RSA). We hypothesized that the BIO-RSA would lead to lower notching rates and improved range of motion (ROM) compared with a tRSA. METHODS: A retrospective review was performed of 69 tRSAs and 61 BIO-RSAs performed by a single surgeon. At 2 years postoperative, ROM and Constant scores were compared. Radiographs were examined for scapular notching, scapular spurring or ossification, and graft healing. RESULTS: At the 2-year follow-up, the BIO-RSA group demonstrated improved anterior forward flexion compared with the tRSA group (145° ± 20° vs. 138° ± 20°, respectively; P = .017). There was no difference in external or internal rotation between the 2 groups. The BIO-RSA group had a higher Constant score than the tRSA group (69 ± 9 vs. 61 ± 13; P < .001). The radiographs showed no difference between the 2 groups, including scapular notching (P = .150). CONCLUSION: At the 2-year follow-up, BIO-RSA does not lead to a clinically significantly improvement in ROM, Constant scores, or change in scapular notching compared with a tRSA.
Authors: Sarav S Shah; Benjamin T Gaal; Alexander M Roche; Surena Namdari; Brian M Grawe; Macy Lawler; Stewart Dalton; Joseph J King; Joshua Helmkamp; Grant E Garrigues; Thomas W Wright; Bradley S Schoch; Kyle Flik; Randall J Otto; Richard Jones; Andrew Jawa; Peter McCann; Joseph Abboud; Gabe Horneff; Glen Ross; Richard Friedman; Eric T Ricchetti; Douglas Boardman; Robert Z Tashjian; Lawrence V Gulotta Journal: JSES Int Date: 2020-09-07